Auro Laboratories Ltd.
| BSE: 530233 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE292C01011 |
| BSE 00:00 | 13 Apr | 86.60 |
3.15 (3.77%) |
OPEN
83.45 |
HIGH
87.75 |
LOW
82.15 |
| NSE 05:30 | 01 Jan | Auro Laboratories Ltd |
| OPEN | 83.45 |
| PREVIOUS CLOSE | 83.45 |
| VOLUME | 11545 |
| 52-Week high | 128.40 |
| 52-Week low | 35.15 |
| P/E | 8.79 |
| Mkt Cap.(Rs cr) | 54 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Auro Laboratories Ltd. (AUROLABS) - Cash Flow
| Figures in Rs crore | 2020 | 2019 | 2018 |
| Opening Cash & Cash Equivalents | 4.11 | 2.25 | 1.01 |
| Net Cash From Operating Activities | 9.19 | 6.87 | 6.05 |
| Net Cash Used In/from Investing Activities | -2.21 | -3.19 | -3.04 |
| Net Cash Used In/from Financing Activities | -5.40 | -1.83 | -1.77 |
| Net (decrease)/increase In Cash and Cash Equivalents |
1.58 | 1.86 | 1.24 |
| Closing Cash & Cash Equivalents | 5.68 | 4.11 | 2.25 |
Quick Links for Auro Laboratories:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
